Compare moats
Up to three covered companies, band by band. Every call is a curated editorial judgment, never a disclosed figure — and every band carries its cited basis.
| GitLab | ChipMOS Technologies | Axcelis Technologies | |
|---|---|---|---|
| Moat rating | narrow The FY2026 10-K (year ended 2026-01-31) shows real expansion inside the installed base: 118% Dollar-Based Net Retention, Base Customers up to 10,682 from 9,893, customers above $100,000 of ARR up to 1,456 from 1,229, and $1.0 million ARR customers "to 155 from 123, an increase of 26%". But the filing concedes "limited barriers to entry" and names "Microsoft Corporation, which owns GitHub" as principal competitor. Retention decelerates (130% FY2024, 123% FY2025, 118% FY2026), and since DBNR is reported "on a threshold basis of 130%," the FY2024 figure is a cap and the slide is steeper than it looks. Narrow, not wide: expansion must be re-won against a bundled hyperscaler. | none ChipMOS earns thin returns in businesses its own 20-F describes as price-driven. The FY2025 20-F reports gross margin of 10.8% in 2025, against 13.0% in 2024. Profit attributable to equity holders was NT$551 million, against NT$1,440 million in 2024 and NT$1,968 million in 2023. The display driver business, 24.5% of 2025 revenue, saw its gross margin fall to 7.5% from 22.5%, which the filing attributes to 'the decline of average selling price'. Its revenue fell 20% on customer inventory adjustments and 'the price competition among DDIC suppliers in Mainland China'. Assembly services ran at a -1.6% gross margin. The filing says prices for its services 'tend to decline over the course of its product and technology life cycle'. Results improved in the 2026 memory upturn: the 2Q26 press release reports an 18% gross margin and the 2Q26 call reports a 14.4% return on equity. One strong quarter in a memory upturn does not offset profits that fell in both 2024 and 2025, so the rating is none. | narrow Axcelis's FY2025 10-K describes a protected but contested position. On the durable side, it says 'Axcelis and Applied Materials are the only ion implant system manufacturers with a full range of implant products'. About 3,400 Axcelis products are in use in 27 countries, and they feed an aftermarket business (CS&I) that earned $268.0 million, or 31.9% of 2025 revenue. The company holds 169 active U.S. patents and 356 active patents granted in other countries. On the limiting side, the risk factors say the ion implant segment 'includes one company with substantially greater financial, engineering, manufacturing, marketing and customer service and support resources', as well as 'several smaller companies that could provide innovative systems'. U.S. export controls 'exacerbate the risk that Chinese customers will change suppliers to non-U.S. vendors', while Kingstone Semiconductor and CETC 'continue to develop ion implanters for the Chinese domestic market'. 'None of our customers have entered into a long-term agreement requiring it to purchase our products.' Revenue fell to $839.0 million in 2025 from $1,017.9 million in 2024. A full-line position with a large installed base, against a better-resourced rival and new Chinese entrants, is a narrow moat. |
| Moat type | switching costs Stickiness comes from platform embedding, not IP. The 10-K rests differentiation on "our single platform with a unified data model," on "Consolidation of multiple tools into a single platform," and on deployment inside the customer's own perimeter for regulated buyers. Replacement means re-integrating a toolchain and re-certifying compliance. IP is the wrong label: only "16 issued patents and 25 pending patent applications," plus open-source licenses granting "broad permissions to use, copy, modify, and redistribute." The no-lock-in claim is the filing's own characterisation, footnoted to a Forrester study "commissioned by GitLab." | none None of the moat sources is supported. Switching costs are low: the 20-F says customer qualification 'typically takes up to eight weeks', that test correlation 'typically takes up to two weeks', and that most customers buy through purchase orders with 'three-month non-binding rolling forecasts'. Scale sits elsewhere: TrendForce's 2024 ranking (2025-05-13) places ChipMOS tenth among OSATs at $710M, against $2.28B for Powertech, which TrendForce (2026-01-12) calls the world's leading DRAM and NAND test and packaging provider. IP is not decisive: the 20-F lists the measures of competitiveness in testing as software engineering, quality of service, flexibility, capacity, production cycle time and price. It names ASE, Amkor, Chipbond, KYEC, Powertech, JCET and UTAC as competitors, alongside IDMs with in-house capacity. | intangibles ip The FY2025 10-K grounds the advantage in owned implant technology rather than contractual lock-in. Its Purion implanters share 'a common platform which enables a unique combination of implant purity, precision, and productivity', and its high energy systems use 'production-proven RF Linac high energy, spot beam technology'. System assembly and testing stays in-house 'due to the high degree of expertise and intellectual property associated with the process and design'. The company holds 169 active U.S. and 356 foreign patents, though it says it is not 'substantially dependent on any single patent or any group of patents'. The installed base supports aftermarket revenue but does not lock customers in: the risk factors say customers often train 'their own staff to maintain and service' equipment and buy parts that are not patent-protected from third parties. Switching costs are therefore the weaker candidate. |
| Leadership | fast follower The 10-K positions GitLab against a leader rather than as one: "Our principal competitor is Microsoft Corporation, which owns GitHub." Competition reads from the challenger side, differentiating "from GitHub through flexible deployment options that work within enterprise security and compliance requirements, LLM neutrality with self-hosted gateway support" and an open core model. On AI it follows: Duo Agent Platform went "Generally available in January 2026," the last month of the fiscal year. What keeps it a follower rather than behind is cadence, "a new version of our software every month for 172 months in a row," plus a regulated-deployment franchise a SaaS-first rival does not cover. | at parity TrendForce's 2024 ranking (2025-05-13) places ChipMOS tenth among global OSATs with $710M in revenue, and credits its driver IC business with 'steady demand in the automotive and OLED sectors'. Powertech's 2025 annual report, compiled from Taiwan's Market Observation Post System, shows ChipMOS revenue of NT$23,933 million in 2025, against NT$21,454 million for Chipbond, a competitor the 20-F names, and NT$74,929 million for Powertech. The 20-F calls ChipMOS 'one of the leading independent providers' of display driver and memory testing and assembly in Taiwan, which is its own description. No source shows a lead over peers, so the band is at_parity. | fast follower The FY2025 10-K says 'In the market for ion implantation systems, we mainly compete against Applied Materials' and that the two 'are the only ion implant system manufacturers with a full range of implant products'. It claims Axcelis 'has been a market leader in high energy ion implanters for many years' and is 'a technology leader and supplier of choice' in power devices. But its risk factors say the implant segment includes 'one company with substantially greater' resources (unnamed there; Applied Materials is the main rival it names), and it lists 'Achieve market share leadership across all served markets' as a 2026 goal rather than a current fact. No third-party market-share source was fetched, so these are the company's own claims. Which of the two full-line suppliers has the larger overall share is not established by the sources read. Because the only basis for a shared lead is the company's own description, and that description treats share leadership as a goal not yet met, the band is held at fast_follower rather than co_leader. |
| Pricing power | moderate FY2026 gross margin was 87% against 89%, with cost of revenue up $35.6 million "primarily due to an increase of $18.4 million in third party hosting costs for SaaS and cloud usage," and management expects SaaS and Duo mix to bring costs that "may adversely impact our gross margins." Strain is explicit: GitLab "may be required to reduce our prices," competitors "may offer their products and services at a lower price or for free," and it "implemented user limits on our free SaaS product." Power retained: Premium lists at $29 per user/month billed annually, and seats bundle $12 and $24 of GitLab Credits. But "A majority of our subscriptions are on a one-year period." | weak The 20-F says its service fees 'tend to decline in tandem with the declining average selling prices of the products we test and assemble'. It says memory fees 'were sharply reduced in tandem with' falling DRAM and flash prices in the past. Display driver gross margin fell to 7.5% from 22.5% in 2025 on falling selling prices. In the 2026 upturn the company is passing costs through: on the 2Q26 call the chairman said rising costs for substrates, lead frames and gold will be passed on to customers, and gross margin reached 18.0%. That is cost recovery in a tight market, not durable pricing power. | moderate The FY2025 10-K reports gross margin of 44.9% in 2025 against 44.7% in 2024. That held steady while revenue fell from $1,017.9 million to $839.0 million, but its risk factors warn that 'if we must lower prices to remain competitive without commensurate cost of goods savings, our gross margin and profitability will be adversely affected'. They also say that if suppliers raise component costs, Axcelis 'may not be able to raise the price of our products to cover all or part of the increased cost'. On the Q2 2026 call (https://www.marketbeat.com/earnings/reports/2026-8-5-axcelis-technologies-inc-stock/), management reported a non-GAAP gross margin of 42.7% (the call states its income-statement measures are non-GAAP unless noted, so it is not directly comparable with the 10-K's GAAP figures), 'slightly below our outlook of 43%', citing CS&I mix and higher than anticipated services costs. |
| Summary | GitLab sells a single-platform DevSecOps toolchain defended by workflow lock-in rather than intellectual property: a unified data model plus deployment flexibility, including single-tenant "Dedicated for Government with FedRAMP compliance," makes it hard to remove where data residency is contractual. The installed base expands: 118% Dollar-Based Net Retention, 10,682 Base Customers, 1,456 above $100,000 of ARR, 155 above $1.0 million (up 26%), over 70% of ARR from public sector and enterprise. The filing supplies the counterweight: "limited barriers to entry," Microsoft/GitHub as principal competitor, 16 issued patents. Retention (130 to 123 to 118, the 130 a cap), gross margin (89% to 87%) and a January 2026 AI launch point to compression at the commodity end. No source measures market share, so every share band is "unknown". | ChipMOS is a Taiwanese outsourced assembly and test house (OSAT) with plants in Hsinchu and Tainan. In 2025, memory and logic/mixed-signal testing was 23.7% of revenue, assembly 28.6%, display driver assembly and test 24.5% and bumping 23.2%. Its top five customers took 61% of revenue, and its top fifteen include Micron, Novatek, Himax, Nanya, Winbond, Macronix and MediaTek. The memory upturn has shifted the mix. On the 2Q26 call, memory was 51% of revenue and display drivers 18.1%, overall utilization was 72%, and management said it 'selectively raised the memory OSAT price' to reflect material costs. 2Q26 revenue of NT$7,383.1 million was the highest since 2014. TrendForce (2026-01-12) cites analysts saying that DRAM, 'led by DDR4, which makes up roughly 70–80% of memory sales', remains the company's 'core earnings driver'. Management is reallocating capacity. It signed a three-year memory wafer test take-or-pay contract in early 2026, it is 'monetizing the low-end and lower UT level DDIC assets', and it plans to add testing capacity for AI ASICs and silicon photonics. The verdict is no moat: a capable mid-sized OSAT whose margins follow memory prices and Chinese display-driver competition. | Axcelis is an ion-implant specialist. The FY2025 10-K says implantation was 98.2% of 2025 revenue, sold as the Purion family of high energy, high current and medium current single-wafer implanters, the Ovation batch implanters, and aftermarket parts, upgrades and services. Its strongest ground is power devices. Axcelis calls itself 'a technology leader and supplier of choice in the implant-intensive power device segment', which made up 55% of the value of 2025 system shipments, and its Purion Power Series covers silicon carbide wafers. 2025 was a down year: revenue fell to $839.0 million from $1,017.9 million, systems backlog to $457.0 million from $645.8 million, and operating profit to $119.3 million from $210.8 million, while gross margin held at 44.9%. The 10-K names Applied Materials as the main rival and the only other full-range implant maker; other competitors include Sumitomo Heavy Industries Ion Technology, Nissin Ion Equipment, Advanced Ion Beam Technology and two Chinese developers. Among its 2026 goals the company lists 'Achieve market share leadership across all served markets', which it has not yet reached. On the Q2 2026 call (https://www.marketbeat.com/earnings/reports/2026-8-5-axcelis-technologies-inc-stock/), management said electric vehicles remain the number one driver of silicon carbide demand. It also said it expects its merger with Veeco, under which each Veeco share converts into 0.3575 Axcelis shares according to the 10-K, to close in the second half of 2026, pending approval in China. |
| Chain position | GitLab sits at the software-tooling layer, not compute or models. It consumes third-party LLM capacity — marketing "LLM neutrality and support for self-hosted AI gateways, including air-gapped environments" — so it captures no model-layer economics and bears inference as COGS, visible in the $18.4 million rise in hosting costs. Its distinctive position is the regulated perimeter. | Back-end assembly and test supplier to memory makers and display-driver designers. Customers headquartered in Taiwan were 87% of 2025 revenue, per the 20-F. | A front-end wafer-fab equipment supplier to chipmakers, concentrated in Asia and in power devices. The FY2025 10-K says implanter shipments to Asian customers were 76.0% of 2025 system revenue, international sales 83.7% of total revenue, and the top ten customers 55.2% of net sales. It also says sales to Chinese customers are expected to remain significant under U.S. export-control licensing. |
| Products (share / barrier) |
|
|
|
| Long-horizon vote | +0.06 at weight 0.20 · swarm neutral Editorial prior, not backtested. | -0.06 at weight 0.20 · swarm bearish Editorial prior, not backtested. | +0.06 at weight 0.20 · swarm bearish Editorial prior, not backtested. |